Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Gentian Diagnostics

Less than 1K followers

GENT

Oslo Børs

Medical Equipment & Services

Health Care

Overview
Investor consensus

Gentian Diagnostics is a medical diagnostics company that develops and manufactures in vitro diagnostic reagents for high-throughput analysers. Gentian’s expertise and focus lies within homogenous immunoassays, specifically infections, inflammations, kidney failures and congestive heart failures. The company headquarters and production facilities are located in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in key countries.

Read more
Market cap
-
Turnover
-
Revenue
152.07M
EBIT %
10.34 %
P/E
-
Dividend yield-%
-
Financial calendar
11.2
2026

Annual report '25

5.5
2026

General meeting '26

6.5
2026

Interim report Q1'26

All
Press releases
ShowingAll content types
Regulatory press release11/25/2025, 7:10 AM

GENT: Gentian Diagnostics presents at the DNB Nordic Healthcare Conference

Gentian Diagnostics
Regulatory press release11/11/2025, 10:32 AM

GENT: Financial calendar

Gentian Diagnostics
Regulatory press release10/28/2025, 7:41 AM

GENT: Mandatory notification of trade

Gentian Diagnostics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release10/23/2025, 8:15 AM

Gentian Diagnostics: Study Confirms the Value of Calprotectin in Early Detection of Neonatal Infections and Sepsis

Gentian Diagnostics
Regulatory press release10/23/2025, 6:00 AM

Gentian Diagnostics: Third quarter 2025 report

Gentian Diagnostics
Regulatory press release10/16/2025, 7:55 AM

Gentian Diagnostics: Invitation to presentation of third quarter results

Gentian Diagnostics
Regulatory press release9/16/2025, 6:11 AM

GENT: Gentian Diagnostics presents at the Pareto Securities Healthcare conference

Gentian Diagnostics
Regulatory press release7/10/2025, 6:00 AM

Gentian Diagnostics: Second quarter 2025 report

Gentian Diagnostics
Regulatory press release7/3/2025, 11:22 AM

Gentian Diagnostics: Invitation to presentation of second quarter results

Gentian Diagnostics
Regulatory press release5/23/2025, 9:39 AM

GENT: Disclosure of shareholding

Gentian Diagnostics
Regulatory press release5/22/2025, 8:47 AM

GENT: Disclosure of large shareholding

Gentian Diagnostics
Regulatory press release5/8/2025, 8:00 AM

GENT: Mandatory notification of trade

Gentian Diagnostics
Regulatory press release5/7/2025, 6:07 AM

Gentian Diagnostics: Ex dividend NOK 0.40 today

Gentian Diagnostics
Regulatory press release5/7/2025, 6:00 AM

Gentian Diagnostics: First quarter 2025 report

Gentian Diagnostics
Regulatory press release5/6/2025, 10:14 AM

Gentian Diagnostics: Minutes from Annual General Meeting

Gentian Diagnostics
Regulatory press release4/30/2025, 8:10 AM

Gentian Diagnostics: Invitation to presentation of first quarter results

Gentian Diagnostics
Regulatory press release4/11/2025, 10:56 AM

Gentian Diagnostics: Notice of annual general meeting

Gentian Diagnostics
Regulatory press release4/7/2025, 12:23 PM

GENT: Mandatory notification of trade

Gentian Diagnostics
Regulatory press release3/28/2025, 9:30 AM

GENT: Gentian Diagnostics strengthens commercial capabilities with key appointments

Gentian Diagnostics
Regulatory press release3/21/2025, 1:58 PM

Correction: Gentian Diagnostics: Annual report 2024

Gentian Diagnostics
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.